Therapy: Challenging the course of RA: time for drug-free remission?
Aletaha
Daniel
D
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004185:Disability Evaluation; D004334:Drug Administration Schedule; D006304:Health Status; D006801:Humans; D000069285:Infliximab; D010818:Practice Patterns, Physicians'; D012075:Remission, Spontaneous; D012720:Severity of Illness Index; D000079424:Tumor Necrosis Factor Inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000079424:Tumor Necrosis Factor Inhibitors; D000069285:Infliximab